Infectious Diseases and Therapy,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 30, 2024
Vaccination
represents
a
core
preventive
strategy
for
public
health,
with
interrelated
and
multifaceted
effects
across
health
socioeconomic
domains.
Beyond
immediate
disease
prevention,
immunization
positively
influences
downstream
outcomes
by
mitigating
complications
of
preexisting
comorbidities
promoting
healthy
aging.
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
influenza
virus,
syncytial
virus
(RSV)
are
common
viruses
responsible
broad
societal
cost
substantial
morbidity
mortality,
particularly
among
at-risk
individuals,
including
older
adults
people
frailty
or
certain
comorbid
conditions.
In
this
narrative
review,
we
summarize
the
overall
impact
vaccination
these
3
viruses,
focusing
on
mRNA
vaccines,
each
which
exhibits
unique
patterns
infection,
risk,
transmission
dynamics,
but
collectively
represent
target
strategies.
Vaccines
COVID-19
(caused
SARS-CoV-2)
effective
against
most
severe
outcomes,
such
as
hospitalization
death;
vaccines
potent
cost-effective
interventions
protection
population
individual
influenza,
those
Based
promising
results
efficacy
prevention
RSV-associated
lower
tract
disease,
first
RSV
were
approved
in
2023.
Immunization
strategies
should
account
various
factors
leading
to
poor
uptake,
vaccine
hesitancy,
barriers
access,
cultural
beliefs,
lack
knowledge
states.
Coadministration
combination
multicomponent
offer
potential
advantages
logistics
delivery,
thus
improving
uptake
reducing
adoption
new
vaccines.
The
success
platform
was
powerfully
demonstrated
during
pandemic;
other
approaches
show
promise
means
overcome
existing
challenges
development
sustain
viral
changes
over
time.A
graphical
abstract
video
is
available
article.
Vaccines,
Journal Year:
2022,
Volume and Issue:
10(12), P. 2026 - 2026
Published: Nov. 26, 2022
This
study
systematically
analyzed
the
literature
using
theory
of
planned
behavior
(TPB)
as
a
theoretical
framework
to
examine
influence
its
constructs
on
vaccination
intention
against
COVID-19.
Quantitative
studies
were
searched
in
PubMed,
CINAHL,
Web
Science,
and
Google
Scholar
following
PRISMA
guidelines.
The
average
rate
COVID-19
was
73.19%,
ranging
from
31%
88.86%.
Attitude
had
strongest
association
with
(r+
=
0.487,
95%
CI:
0.368–0.590),
followed
by
subjective
norms
0.409,
0.300–0.507),
perceived
behavioral
control
0.286,
0.198–0.369).
Subgroup
analyses
showed
that
pooled
effect
sizes
TPB
varied
across
geographic
regions
populations.
large
Asia,
Europe,
Oceania,
especially
among
adult
general
population,
parents,
patients.
Subjective
Asia
parents
Perceived
most
dominant
predictor
acceptance
Africa
These
findings
suggest
provides
useful
for
predicting
receive
vaccine.
Hence,
public
awareness
educational
programs
aimed
at
promoting
should
consider
achieve
goal.
International Journal of Environmental Research and Public Health,
Journal Year:
2023,
Volume and Issue:
20(2), P. 1410 - 1410
Published: Jan. 12, 2023
COVID-19
has
challenged
the
health
workforce
worldwide.
In
this
cross-sectional
study
with
a
retrospective
assessment,
we
explored
impact
of
pandemic
on
mental
and
sleep
among
sample
Italian
nurses
medical
doctors.
A
total
287
healthcare
workers
(212
75
physicians)
completed
web
survey
socio-demographic,
psychological,
sleep-related
aspects
referring
to
period
before
present
February
June
2022.
Comparisons
between
physicians
revealed
that
former
had
greater
distress
in
response
pandemic.
Consistently,
multivariate
analysis
covariance
showed
even
if
both
groups
were
negatively
impacted
by
pandemic,
presented
worsening
over
time
regarding
several
psychological
symptoms.
Furthermore,
observed
working
frontline
represented
an
additional
risk
factor
for
nurses.
line
previous
evidence,
also
found
personal
experiences
are
significant
predictors
current
status.
Our
results
underscore
urgent
need
preventive
programs
operators
increase
their
coping
skills
prevent
long-term
consequences
chronic
stress,
especially
high-risk
professionals.
Specific
attention
should
be
devoted
improve
quality
reduce
traumatic
Bulletin of the National Research Centre/Bulletin of the National Research Center,
Journal Year:
2023,
Volume and Issue:
47(1)
Published: March 21, 2023
Abstract
Background
Since
the
outbreak
of
coronavirus
(COVID-19)
disease
was
reported
in
2019,
huge
human
and
material
resources
have
been
expended
globally
to
combat
spread
disease.
Achieving
herd
immunity
through
mass
vaccination
remains
an
important
strategy
adopt
war
against
this
since
it
is
practically
impossible
for
60–70%
population
achieve
natural
infection
alone.
Unfortunately,
there
widespread
reports
COVID-19
vaccine
hesitancy.
This
study
aims
systematically
review
literature
provide
up-to-date
assessment
acceptance
rates
also
explore
factors
impacting
hesitancy
among
adults
Nigeria.
Main
body
abstract
A
systematic
search
indexed
electronic
peer-reviewed
published
from
2019
onwards
conducted
Science
Direct,
PubMed,
ProQuest,
EBSCOhost
databases
according
PRISMA
checklist
Synthesis
without
meta-analysis
(SWiM)
reporting
guidelines.
Fifteen
out
148
studies
retrieved,
met
inclusion
criteria
these
were
critically
appraised
using
Centre
Evidence-Based
Medicine
Critical
Appraisal
Mixed
Methods
Tool,
version
2018.
Basic
descriptive
statistic
(percentage)
employed
analysis
various
subgroups
Nigeria,
while
a
thematic
facilitators
barriers
uptake
Nigeria
conducted.
Acceptance
ranging
24.3%
49.5%
observed
across
four
high-risk
populations
low-risk
ranged
26.0%
86.2%.
Themes
such
as
socio-demographic
factors,
perception
risk
concerns
about
vaccine's
safety
efficacy
act
interchangeably
vaccines,
whereas
political
conspiracy
theories,
cost
primarily
uptake.
Short
conclusion
Substantial
heterogeneity
More
than
half
reviewed
below
60.0%.
multidisciplinary
approach
recommended
engaging
stakeholders,
effectively
address
BMC Pregnancy and Childbirth,
Journal Year:
2022,
Volume and Issue:
22(1)
Published: Aug. 2, 2022
Pregnant
women
are
at
high
risk
for
affliction
by
coronavirus
disease
2019
(COVID-19).
Vaccination
is
a
main
strategy
to
prevent
and
manage
the
COVID-19
pandemic.
However,
hesitancy
about
vaccination
(HACV)
major
public
health
threat
barrier
herd
immunity.
The
aim
of
study
was
evaluate
pregnant
women's
HACV
based
on
Health
Belief
Model
(HBM).This
cross-sectional
conducted
in
2021-2022.
Participants
were
352
selected
from
several
healthcare
centers
north
Iran.
Instruments
data
collection
demographic
questionnaire,
Knowledge
Questionnaire,
question
HACV.
Logistic
regression
analysis
used
assess
effects
variables
HACV.The
rate
42.61%.
In
model,
three
factors
perceived
benefits
(aOR:
0.700;
95%
CI:
0.594
0.825),
cues
action
0.621;
0.516
0.574),
history
reproductive
problems
2.327;
0.1.262
4.292)
had
significant
(P
<
0.001).HACV
highly
prevalent
among
women.
components
HBM
have
HACV,
while
component
has
no
effect
it.
good
model
explain
Educational
interventions
necessary
improve
awareness
risks
them
their
fetus.
Science in One Health,
Journal Year:
2023,
Volume and Issue:
2, P. 100048 - 100048
Published: Jan. 1, 2023
The
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
pandemic
has
taken
a
toll
on
humans,
and
the
development
of
effective
vaccines
been
promising
tool
to
end
pandemic.
However,
for
vaccination
program
be
successful,
considerable
proportion
community
must
vaccinated.
Hence,
public
acceptance
COVID-19
become
key
controlling
Recent
studies
have
shown
vaccine
hesitancy
increasing
over
time.
This
systematic
review
aims
evaluate
rate
related
factors
in
different
communities.
A
comprehensive
search
was
performed
Medline
(via
PubMed),
Scopus,
Web
Science
from
January
1,
2019
31,
2022.
All
relevant
descriptive
observational
(cross-sectional
longitudinal)
were
included
this
review.
In
meta-analysis,
Odds
Ratio
(OR)
used
assess
effects
population
characteristics
hesitancy,
event
(acceptance
rate)
effect
measure
overall
acceptance.
Publication
bias
assessed
using
funnel
plot,
Egger's
test,
trim-and-fill
methods.
total
135
out
6,417
after
screening.
meta-analysis
114
studies,
including
849,911
participants,
showed
an
63.1%.
addition,
men,
married
individuals,
educated
people,
those
with
history
flu
vaccination,
higher
income
levels,
comorbidities,
people
living
urban
areas
less
hesitant.
Increasing
awareness
importance
overcoming
is
crucial.
Being
region,
being
or
educated,
having
influenza
level
status,
comorbidities
are
associated
Frontiers in Public Health,
Journal Year:
2023,
Volume and Issue:
11
Published: March 28, 2023
Background
Seasonal
influenza
vaccine
can
reduce
the
risk
of
influenza-associated
hospitalizations
and
deaths
among
children.
Given
that
parents
are
primary
decision
makers,
this
study
examined
parental
attitude
toward
childhood
identified
determinants
hesitancy
(VH)
in
Eastern
Mediterranean
region
(EMR).
Methods
A
cross-sectional
was
conducted
using
an
anonymous
online
survey
14
EMR
countries.
Parents
children
aged
6
months
to
18
years
were
included.
The
Parent
Attitude
about
Childhood
Vaccines
(PACV)
used
assess
VH.
Chi
square
test
independent
t-test
for
association
qualitative
quantitative
variables,
respectively.
structural
equations
model
(SEM)
identify
direct
indirect
Results
Almost
half
hesitant
vaccinating
their
against
(50.8%).
Parental
VH
significantly
higher
older
mothers
(37.06
±
8.8
years,
p
=
0.006),
rural
residents
(53.6%,
<
0.001),
high-income
countries
(50.6%,
with
educational
levels
(52.1%,
0.001).
school-aged
(5–9
years)
(55.6%,
free
from
any
comorbidities
(52.5%,
who
did
not
receive
routine
vaccination
at
all
(51.5%,
0.03),
vaccinated
COVID-19
(54.3%,
addition
(57.1%,
0.001)
associated
increased
likelihood
depending
on
healthcare
provider
as
a
source
information
regarding
vaccines
less
likely
report
(47.9%,
meanwhile
those
social
media
health
showed
(57.2%,
SEM
suggested
mother’s
age,
residence,
country
income
level,
child
gender,
total
number
had
effect
Meanwhile,
influenza,
completely
or
partially
Coronavirus
disease
2019
(COVID-19)
Conclusion
high
proportion
included
vaccinate
seasonal
influenza.
This
is
due
many
modifiable
non-modifiable
factors
be
targeted
improve
coverage.
mSystems,
Journal Year:
2023,
Volume and Issue:
8(2)
Published: March 2, 2023
Over
the
past
150
years,
vaccines
have
revolutionized
relationship
between
people
and
disease.
During
COVID-19
pandemic,
technologies
such
as
mRNA
received
attention
due
to
their
novelty
successes.
However,
more
traditional
vaccine
development
platforms
also
yielded
important
tools
in
worldwide
fight
against
SARS-CoV-2
virus.
A
variety
of
approaches
been
used
develop
that
are
now
authorized
for
use
countries
around
world.
In
this
review,
we
highlight
strategies
focus
on
viral
capsid
outwards,
rather
than
nucleic
acids
inside.
These
fall
into
two
broad
categories:
whole-virus
subunit
vaccines.
Whole-virus
virus
itself,
either
an
inactivated
or
attenuated
state.
Subunit
contain
instead
isolated,
immunogenic
component
Here,
candidates
apply
these
different
ways.
a
companion
manuscript,
review
recent
novel
nucleic-acid
based
technologies.
We
further
consider
role
programs
played
prophylaxis
at
global
scale.
Well-established
proved
especially
making
accessible
low-
middle-income
countries.
Vaccine
established
undertaken
much
wider
range
those
using
nucleic-acid-based
technologies,
which
led
by
wealthy
Western
Therefore,
platforms,
though
less
from
biotechnological
standpoint,
proven
be
extremely
management
SARS-CoV-2.
npj Digital Medicine,
Journal Year:
2023,
Volume and Issue:
6(1)
Published: May 25, 2023
Chatbots
have
become
an
increasingly
popular
tool
in
the
field
of
health
services
and
communications.
Despite
chatbots'
significance
amid
COVID-19
pandemic,
few
studies
performed
a
rigorous
evaluation
effectiveness
chatbots
improving
vaccine
confidence
acceptance.
In
Thailand,
Hong
Kong,
Singapore,
from
February
11th
to
June
30th,
2022,
we
conducted
multisite
randomised
controlled
trials
(RCT)
on
2,045
adult
guardians
children
seniors
who
were
unvaccinated
or
had
delayed
vaccinations.
After
week
using
chatbots,
differences
acceptance
compared
between
intervention
control
groups.
Compared
non-users,
fewer
chatbot
users
reported
decreased
Thailand
child
group
[Intervention:
4.3
%
vs.
Control:
17%,
P
=
0.023].
However,
more
[26%
12%,
0.028]
Kong
safety
[29%
10%,
0.041]
Singapore
group.
There
was
no
statistically
significant
change
senior
Employing
RE-AIM
framework,
process
indicated
strong
implementation
support
for
stakeholders,
with
high
levels
sustainability
scalability.
This
multisite,
parallel
RCT
study
found
mixed
success
among
Asian
subpopulations.
Further
that
link
usage
real-world
uptake
are
needed
augment
evidence
employing
advance
Journal of Medical Virology,
Journal Year:
2024,
Volume and Issue:
96(2)
Published: Feb. 1, 2024
Abstract
With
the
approval
of
first
vaccines
against
respiratory
syncytial
virus
(RSV)
and
a
novel
RSV‐neutralizing
antibody,
2023
has
been
perceived
as
game‐changing
year
in
preventing
severe
outcomes
RSV
infections
infants
elderly.
However,
costs
these
pharmaceuticals
are
high,
while
disproportionately
impacts
populations
low‐to‐middle‐income
regions,
which
may
continue
to
suffer
from
lack
pharmaceutical
measures
for
prevention
under
health
socioeconomic
disparities.
This
paper
presents
an
overview
characteristics,
clinical
results,
status
various
anti‐RSV
antibodies.
It
posits
that
wealthy
nations
cannot
monopolize
immunoprophylaxis
should
work
jointly
make
it
available
lower‐income
countries.
An
approach
toward
equity
based
on
five
points
is
offered:
(1)
integration
antibodies
into
existing
global
humanitarian
distribution
systems,
(2)
using
affordable
vaccine
pricing
models,
(3)
enforcing
part
national
public
strategy,
(4)
implementing
equitable
allocation
frameworks
immunoprophylaxis,
(5)
promoting
local
manufacturing.
Such
plan
needs
be
put
action
soon
possible
avoid
delays
serving
with
highest
related
burden.